Cargando…
Retraction: Linc00472 suppresses breast cancer progression and enhances doxorubicin sensitivity through regulation of miR-141 and programmed cell death 4
Retraction of ‘Linc00472 suppresses breast cancer progression and enhances doxorubicin sensitivity through regulation of miR-141 and programmed cell death 4’ by Pengwei Lu et al., RSC Adv., 2018, 8, 8455–8468, DOI: 10.1039/C8RA00296G
Autor principal: | Fisher, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694806/ https://www.ncbi.nlm.nih.gov/pubmed/35427065 http://dx.doi.org/10.1039/d1ra90067f |
Ejemplares similares
-
Retracted Article: Linc00472 suppresses breast cancer progression and enhances doxorubicin sensitivity through regulation of miR-141 and programmed cell death 4
por: Lu, Pengwei, et al.
Publicado: (2018) -
LINC00472 suppresses oral squamous cell carcinoma growth by targeting miR-455-3p/ELF3 axis
por: Liu, Xiu, et al.
Publicado: (2022) -
Retracted: Comprehensive Analysis of Regulatory Network for LINC00472 in Clear Cell Renal Cell Carcinoma
por: Healthcare Engineering, Journal of
Publicado: (2023) -
LINC00472 suppressed by ZEB1 regulates the miR‐23a‐3p/FOXO3/BID axis to inhibit the progression of pancreatic cancer
por: Bi, Cong, et al.
Publicado: (2021) -
Linc00472 suppresses proliferation and promotes apoptosis through elevating PDCD4 expression by sponging miR-196a in colorectal cancer
por: Ye, Yafei, et al.
Publicado: (2018)